To answer the original question of the thread, it is making up...

To answer the original question of the thread, it is making up for CAN having run harder in recent times/yesterday.

The AC8 having all licences point is a dud argument by AC8, they love mentioning it in every release because it is the only point of difference over CAN they want to try to hang their hat on, and the AC8 announcements scream of being CAN conscious. But regardless, like the other licences, CAN will get a manufacturing licence as soon as they want one. They will seek this as part of the third facility to be built this year as outlined in CAN's announcements. Any manufacturing in the meantime is being done by a contract manufacturer. At the moment CAN's material is going to the Victorian Health Department for pediatric epilepsy trials, so the assumption is the Govt is doing the contract manufacturing for the current CAN supply. Very nice arrangement.

@Levelgrinder is incorrect on a number of fronts, main one being that CAN is the only ASX-listed player with an export licence. Similarly CAN is the only one in Australia with a PERMIT to grow product (the licences are only the first step, you need a permit on top of that to actually start growing).

@Shandog raises a good point, but there are some very hungry instos out there for this stock who are likely soaking up the selling, just look at the Tweets from Regal Funds Management's Julian Babarczy, one of various big name instos in CAN (not to mention Aurora 'creeping' to 22.9% shareholding as part of the capital raising).

@blueballs why would you compare undiluted market cap? AC8 has the messy structure with heaps of performance shares and options, all of which will be vested/satisfied given the share price run of AC8. Only worth looking at fully diluted market cap, and AC8 is very close to CAN at current prices.

As many have said in here if you like the space you may as well hold both... people are posting too much about which is the best/worth the most/valued ahead of the other.... the market will be big enough for more than one player. CAN and AC8 are deservedly the highest market caps at this point in terms of the ASX-listed players.

As I've said before though, CAN deserves to be ahead of the others. Clear first mover advantage (including yesterday's announcement from the Feds Govt as a great example, CAN had announcement out first and got huge media attention from it, obviously had inside running), first licences from the ODC, only one with a PERMIT to grow here, first one to harvest product here, partnership with AgVic/Vic Health who are taking product cultivated thus far. It now also has huge war chest from the cap raising and soon to start construction of a 16k metre squared facility. On top of that Canadian major Aurora creeping from 19.9% to 22.9% in the raising plus recently adding one of its executives to the CAN board, screams of a takeover at some point.

All IMHO/DYOR